FDA | GovernmentCIO Media & Research

FDA

Technological solutions could provide relief to medical facilities in urgent need of necessary equipment.
The technology is one way to solve national shortages of medical supplies during the COVID-19 pandemic.
The molecular diagnostics test is the fastest test for the novel coronavirus in the U.S.
Global health leaders are calling attention to the world's other leading infectious diseases like tuberculosis.
Data can accelerate the approval processes for new drugs and medical devices.
A GAO report highlights policy areas as the FDA considers regulatory rules around the technology.
Agencies find opportunity in increasing diversity within cyber programs and leveraging shared services.
Health agencies point to a need for modernized IT infrastructure and data-driven decisions.
The emerging technologies can predict, anticipate and protect against dangerous chemicals in the U.S. food supply.
The center uses significant data processes and analytics in the effort to curb tobacco-related disease and death.
The Digital Health Pre-Cert Pilot Program continues despite commissioner's recent resignation announcement.
Companies are deploying artificial intelligence without standardized ethics or measured implications.
By all assessments, artificial intelligence has a bright future in health care.
It can't offer a soothing smile or strike an inspirational doctor pose, but it can help improve recovery.
But it can’t be scaled without “a vote of confidence that it protects and promotes patients."
Leveraging the cloud is also part of FDA’s strategic plan.
And next year’s goals include stronger interoperability, APIs and microservices
The FDA sees digital transformation as consisting of simultaneous technical and workforce reforms.
"We realized how important it was to get tactical."